Showing 4921-4930 of 5623 results for "".
- Alcon Provides Update on COVID-19https://modernod.com/news/alcon-provides-update-on-covid-19/2477538/Alcon announced a series of updates stemming from the impact of COVID-19. Alcon has initiated business continuity plans designed to keep its associates and customers safe while continuing to deliver critical eye care needs for the global healthcare community. These plans include directing
- Inovio Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Todayhttps://modernod.com/news/inovio-initiates-phase-1-clinical-trial-of-its-covid-19-vaccine-and-plans-first-dose-today/2477532/Inovio Pharmaceuticals announced that the FDA has accepted the company’s investigational new drug (IND) application for INO-4800, its DNA vaccine candidate designed to prevent COVID-19 infection, paving the way for phase 1 clinical testing of INO-4800 in healthy volunteers beginning this we
- OD-OD Introduces a New Learning App for Retinal Laser Treatmenthttps://modernod.com/news/od-od-introduces-a-new-learning-app-for-retinal-laser-treatment/2479529/To address growing demand for interactive learning technology, OD-OS has developed a tool for implementing a better approach to retinal laser treatment: The Navigate App. Navigate is a free, interactive tool designed to support residents and team education—both onsite and online. The platf
- ProtoKinetix AAGP Exhibits Efficacy and Safety in Model of Dry Eye Diseasehttps://modernod.com/news/protokinetix-aagp-exhibits-efficacy-and-safety-in-model-of-dry-eye-disease/2479530/ProtoKinetix, which recently announced filing for patent protection for new applications of its AAGP (PKX-001) molecule, announced preliminary results in efficacy and safety for use in treating dry eye disease (DED). PKX-001 demonstrated a protective effect in the murine model of dry eye d
- BlephEx Announces Appeal Victory In Patent Litigation With Myco Industrieshttps://modernod.com/news/blephex-announces-appeal-victory-in-patent-litigation-with-myco-industries/2479532/BlephEx, creator of the BlephEx device and eyelid cleaning procedure, announced a victory before the Court of Appeals for the Federal Circuit in its ongoing patent litigation with Myco Industries
- CRST: Hydroxychloroquine for the Treatment and Prevention of COVID-19https://modernod.com/news/hydroxychloroquine-for-the-treatment-and-prevention-of-covid-19/2477524/A new article published online in Cataract & Refractive Surgery Today (CRST) provides an in-depth examination of the use of hydroxychloroquine for both prophylaxis a
- Provider Initiative to Help Ease Financial and Administrative Stress During Coronavirus Pandemichttps://modernod.com/news/provider-initiative-to-help-ease-financial-and-administrative-stress-during-coronavirus-pandemic/2477522/Humana announced a series of actions designed to help provide financial and administrative relief for the health care provider community facing the COVID-19 pandemic. First, Humana is implementing simplified and expedited claims processing in order to get reimbursement payments to provider
- Retina Specialists in US Hot Zones Report on How Offices, ORs Have Changed During COVID-19 Spreadhttps://modernod.com/news/retina-specialists-in-us-hot-zones-report-on-how-offices-ors-have-changed-during-covid-19-spread/2477521/New Retina Radio, Retina Today’s podcast, featured a conversation with three doctors from hotspots in the United States. John W. Kitchens, MD, moderated a conversation with George Williams, MD, from the Oakland University School of Medicine, outside of Detroit; Gwen Cousins, MD, from Ret
- SightGlass Vision Reports Positive Interim Data From Pivotal Clinical Trial of Novel Eyeglasses for Myopia Management in Childrenhttps://modernod.com/news/sightglass-vision-reports-positive-interim-data-from-pivotal-clinical-trial-of-novel-eyeglasses-for-myopia-management-in-children/2477515/SightGlass Vision announced topline results from a planned 12-month interim analysis of the company’s pivotal trial evaluating its novel eyeglasses designed to slow the progression of myopia in children. Data from the Control of Myopia Using Peripheral Diffusion Lenses: Efficacy and Safety
- Philadelphia Teen Fires Up His 3D Printers to Create Face Shields to Donate to Hospitalshttps://modernod.com/news/philadelphia-teen-fires-up-his-3d-printers-to-create-face-shields-to-donate-to-hospitals/2477516/Louie Beardell was feeling kind of bored, what with his school on spring break and no chance to get outside and play sports with his buddies. He decided to try to save the world. Or one per